BioTek Launches A Set Of Quantitative Assay Apps To Simplify Detection-Based Applications

The new Quantitative Assay Apps from BioTek Instruments, Inc. provide convenience and simplicity for researchers performing four commonly used detection-based applications: absorbance-based BCA, Bradford, Lowry protein assays, and fluorescence-based DNA assays. These easy-to-use Apps are powered through Gen5 Data Analysis Software and are compatible with BioTek microplate readers equipped with the relevant detection mode, including the popular Cytation and Synergy multi-mode readers.

User-friendly features include pre-defined protocols with simple step-by-step setup, along with quick plate map definition and easy data export. After detection, the Quantitative Assay Apps perform automatic curve fitting as well as concentration normalization and target volume calculations. For more information on the Quantitative Assay Apps, visit www.biotek.com/software./p>

About BioTek Instruments, Inc.
BioTek Instruments, Inc., a part of Agilent and headquartered in Winooski, VT, USA, is a worldwide leader in the design, manufacture, and distribution of innovative life science instrumentation. Our comprehensive product line includes cell imaging systems, microplate readers, washers, dispensers, automated incubators and stackers. These products enable life science research by providing high performance, cost-effective analysis and quantification of biomolecules, biomolecular interactions and cellular structure and function across diverse applications. BioTek espouses a "Think Possible" approach that sets the tone for fresh ideas, unsurpassed customer service and original innovations.